Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP585106.RAn8mEK-gTRbT4mJbEE_s-51au3SJnNzMsH7IGz1ympIc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP585106.RAn8mEK-gTRbT4mJbEE_s-51au3SJnNzMsH7IGz1ympIc130_assertion type Assertion NP585106.RAn8mEK-gTRbT4mJbEE_s-51au3SJnNzMsH7IGz1ympIc130_head.
- NP585106.RAn8mEK-gTRbT4mJbEE_s-51au3SJnNzMsH7IGz1ympIc130_assertion description "[Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP585106.RAn8mEK-gTRbT4mJbEE_s-51au3SJnNzMsH7IGz1ympIc130_provenance.
- NP585106.RAn8mEK-gTRbT4mJbEE_s-51au3SJnNzMsH7IGz1ympIc130_assertion evidence source_evidence_literature NP585106.RAn8mEK-gTRbT4mJbEE_s-51au3SJnNzMsH7IGz1ympIc130_provenance.
- NP585106.RAn8mEK-gTRbT4mJbEE_s-51au3SJnNzMsH7IGz1ympIc130_assertion SIO_000772 17178885 NP585106.RAn8mEK-gTRbT4mJbEE_s-51au3SJnNzMsH7IGz1ympIc130_provenance.
- NP585106.RAn8mEK-gTRbT4mJbEE_s-51au3SJnNzMsH7IGz1ympIc130_assertion wasDerivedFrom befree-2016 NP585106.RAn8mEK-gTRbT4mJbEE_s-51au3SJnNzMsH7IGz1ympIc130_provenance.
- NP585106.RAn8mEK-gTRbT4mJbEE_s-51au3SJnNzMsH7IGz1ympIc130_assertion wasGeneratedBy ECO_0000203 NP585106.RAn8mEK-gTRbT4mJbEE_s-51au3SJnNzMsH7IGz1ympIc130_provenance.